A new flu vaccine has been approved by the US Food and Drug Administration. This vaccine, developed by Moderna, is called mFlusiva. It is notable for being the first non-COVID-related mRNA vaccine to be made publicly available in the US.

The approval of mFlusiva marks a significant development in vaccine technology. Further details about the vaccine and its approval can be found through the US Food and Drug Administration or other reliable sources. Local residents in Galveston may want to seek out more information about mFlusiva and its potential availability in the area.

As more details become available, they can be found through official channels or local news outlets.